Labcorp Holdings (LH) Income from Continuing Operations (2009 - 2026)
Labcorp Holdings' (LH) quarterly Income from Continuing Operations came in at $299.1 million in Q2 2026, up 25.51% year-over-year from $238.3 million in Q2 2025, and up 7.59% quarter-over-quarter from $278.0 million in Q1 2026.
Analysis
Labcorp Holdings (LH) Income from Continuing Operations (2009 - 2026) Analysis & Trends
Labcorp Holdings has disclosed Income from Continuing Operations across 18 years of filings, most recently posting $299.1 million for Q2 2026.
- In Q2 2026, Income from Continuing Operations rose 25.51% year-over-year to $299.1 million; the TTM figure through Jun 2026 stood at $1.0 billion (up 31.26% YoY), while the FY2025 annual figure was $877.7 million, up 17.48% from the prior year.
- Income from Continuing Operations came in at $299.1 million for Q2 2026 at Labcorp Holdings, up from $278.0 million in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of $492.1 million in Q1 2022 to a low of -$166.8 million in Q4 2023.
- Average Income from Continuing Operations over 5 years is $203.2 million, with a median of $210.7 million recorded in 2023.
- Year-over-year, Income from Continuing Operations tumbled 549.6% in 2023 and jumped 186.09% in 2024.
- Over 5 years, Income from Continuing Operations stood at $37.1 million in 2022, then plunged by 549.6% to -$166.8 million in 2023, then jumped by 186.09% to $143.6 million in 2024, then increased by 14.83% to $164.9 million in 2025, then jumped by 81.38% to $299.1 million in 2026.
- Per Business Quant data, the three most recent Income from Continuing Operations figures were $299.1 million in Q2 2026, $278.0 million in Q1 2026, and $164.9 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 49.39 Bn | 48.29 Bn | 486.15 Mn | -66.93 Mn |
| 2 | Quest Diagnostics | 27.49 Bn | 26.86 Bn | 1.03 Bn | 324.00 Mn |
| 3 | Labcorp Holdings | 26.51 Bn | 26.37 Bn | 1.11 Bn | 299.10 Mn |
| 4 | Guardant Health | 23.17 Bn | 22.12 Bn | 219.03 Mn | -120.14 Mn |
| 5 | Tempus AI | 12.59 Bn | 11.77 Bn | 274.25 Mn | 8.51 Mn |
| 6 | Caris Life Sciences | 8.01 Bn | 7.22 Bn | 182.38 Mn | -637,000.00 |
| 7 | Sotera Health | 5.53 Bn | 5.17 Bn | 177.96 Mn | 53.64 Mn |
| 8 | BillionToOne | 4.80 Bn | 4.25 Bn | 77.11 Mn | 8.05 Mn |
| 9 | Adaptive Biotechnologies | 4.40 Bn | 4.05 Bn | 51.39 Mn | -16.21 Mn |
| 10 | iRhythm Holdings | 3.68 Bn | 3.08 Bn | 163.21 Mn | -381,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 299.10 Mn |
| Mar 31, 2026 | 278.00 Mn |
| Dec 31, 2025 | 164.90 Mn |
| Sep 30, 2025 | 261.50 Mn |
| Jun 30, 2025 | 238.30 Mn |
| Mar 31, 2025 | 213.00 Mn |
| Dec 31, 2024 | 143.60 Mn |
| Sep 30, 2024 | 169.60 Mn |
| Jun 30, 2024 | 205.60 Mn |
| Mar 31, 2024 | 228.30 Mn |
| Dec 31, 2023 | -166.80 Mn |
| Sep 30, 2023 | 183.60 Mn |
| Jun 30, 2023 | 155.20 Mn |
| Mar 31, 2023 | 208.40 Mn |
| Dec 31, 2022 | 37.10 Mn |
| Sep 30, 2022 | 277.30 Mn |
| Jun 30, 2022 | 268.00 Mn |
| Mar 31, 2022 | 492.10 Mn |
| Dec 31, 2021 | 371.70 Mn |
| Sep 30, 2021 | 587.80 Mn |